|
gptkbp:instanceOf
|
gptkb:drug
gptkb:bile_acid
|
|
gptkbp:ATCCode
|
A05AA02
|
|
gptkbp:bioavailability
|
60–80%
|
|
gptkbp:brand
|
gptkb:Actigall
gptkb:Destolit
gptkb:Urso
gptkb:Ursofalk
|
|
gptkbp:CASNumber
|
128-13-2
|
|
gptkbp:discoveredBy
|
gptkb:Hiroshi_Shoda
|
|
gptkbp:eliminationHalfLife
|
3.5 to 5.8 days
|
|
gptkbp:excretion
|
feces
|
|
gptkbp:firstIsolatedFrom
|
gptkb:bear_bile
|
|
gptkbp:hasMolecularFormula
|
C24H40O4
|
|
gptkbp:IUPACName
|
gptkb:(3α,5β,7β)-3,7-dihydroxycholan-24-oic_acid
|
|
gptkbp:KEGGID
|
D08668
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:meltingPoint
|
203–204 °C
|
|
gptkbp:MeSH_ID
|
gptkb:D014522
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:pregnancyCategory
|
B (US)
|
|
gptkbp:PubChem_CID
|
gptkb:CHEMBL1405
gptkb:DB01586
4767
4934
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
nausea
diarrhea
abdominal pain
|
|
gptkbp:synonym
|
gptkb:ursodeoxycholic_acid
|
|
gptkbp:UNII
|
724L30Y2RM
|
|
gptkbp:usedFor
|
gptkb:primary_biliary_cholangitis
primary sclerosing cholangitis
dissolving gallstones
|
|
gptkbp:bfsParent
|
gptkb:ursodeoxycholic_acid
|
|
gptkbp:bfsLayer
|
6
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
ursodiol
|